Johnson & Johnson (JNJ) Enterprise Value (2009 - 2026)

Johnson & Johnson has disclosed Enterprise Value across 18 years of filings, most recently posting $592.9 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 70.3% year-over-year to $592.9 billion; the TTM figure through Jun 2026 stood at $592.9 billion (up 70.3% YoY), while the FY2025 annual figure was $480.3 billion, up 47.91% from the prior year.
• Enterprise Value came in at $592.9 billion for Q2 2026 at Johnson & Johnson, up from $556.8 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $592.9 billion in Q2 2026 to a low of $324.7 billion in Q4 2024.
• Average Enterprise Value over 5 years is $407.1 billion, with a median of $393.0 billion recorded in 2022.
• Year-over-year, Enterprise Value fell 19.0% in 2024 and soared 70.3% in 2026.
• Over 5 years, Enterprise Value stood at $393.0 billion in 2022, then retreated by 9.77% to $354.6 billion in 2023, then declined by 8.44% to $324.7 billion in 2024, then soared by 47.91% to $480.3 billion in 2025, then rose by 23.46% to $592.9 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $592.9 billion in Q2 2026, $556.8 billion in Q1 2026, and $480.3 billion in Q4 2025.